Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study
Abstract Multiparametric assays for risk stratification are widely used in the management of both node negative and node positive hormone receptor positive invasive breast cancer. Recent data from multiple sources suggests that different tests may provide different risk estimates at the individual p...
Guardado en:
Autores principales: | John M. S. Bartlett, Jane Bayani, Elizabeth Kornaga, Keying Xu, Greg R. Pond, Tammy Piper, Elizabeth Mallon, Cindy Q. Yao, Paul C. Boutros, Annette Hasenburg, J. A. Dunn, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Cornelis J. H. van de Velde, Robert C. Stein, Daniel Rea |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/86050652dddb40c7bbae488c081d3af4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
por: Jane Bayani, et al.
Publicado: (2017) -
Observers of quantum systems cannot agree to disagree
por: Patricia Contreras-Tejada, et al.
Publicado: (2021) -
Effects of diaphragmatic control on multiparametric analysis of the sniff nasal inspiratory pressure test and inspiratory muscle activity in healthy subjects.
por: Kadja Benício, et al.
Publicado: (2021) -
When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis
por: Kachuck NJ
Publicado: (2011) -
Pathway-based subnetworks enable cross-disease biomarker discovery
por: Syed Haider, et al.
Publicado: (2018)